Sector ratings Lotus Pharmaceutical Co., Ltd.

Equities

End-of-day quote Taiwan S.E. Other stock markets 2024-09-11			5-day change	1st Jan Change
270.50 ^TWD	-2.70%		-1.28%	-0.55%

09-06	Lotus Pharmaceutical Board to Acquire Product Rights of Vietnamese Firm	MT
09-05	Lotus Pharmaceutical Co., Ltd. agreed to acquire Intellectual Property rights of Alpha Choay from Sanofi Vietnam Shareholding Company for $50 million.	CI

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	ESG Refinitiv	Capi. ($)
LOTUS PHARMACEUTICAL CO., LTD.	-	2.23B
ELI LILLY AND COMPANY	C+	829B
NOVO NORDISK A/S	B	583B
JOHNSON & JOHNSON	C+	397B
ABBVIE INC.	C+	344B
MERCK & CO., INC.	B-	291B
ROCHE HOLDING AG	A+	255B
ASTRAZENECA PLC	B+	248B
NOVARTIS AG	B-	232B
AMGEN INC.	C+	177B
PFIZER, INC.	C+	168B
SANOFI	B+	144B
GILEAD SCIENCES, INC.	B-	101B
BRISTOL-MYERS SQUIBB COMPANY	B	98.51B
GSK PLC	B	87.89B
CHUGAI PHARMACEUTICAL CO., LTD	A-	75.39B
DAIICHI SANKYO CO., LTD.	A-	69.9B
TAKEDA PHARMACEUTICAL COMPANY LIMITED	B+	47.01B
HALEON PLC	B	46.8B
Average	B	220.9B
Weighted average by Cap.	B